# Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

> **NCT02416102** · PHASE4 · TERMINATED · sponsor: **University of Miami** · enrollment: 31 (actual)

## Conditions studied

- COPD
- Chronic Bronchitis

## Interventions

- **DRUG:** Losartan 50 mg
- **DRUG:** Losartan 100 mg

## Key facts

- **NCT ID:** NCT02416102
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03-31
- **Primary completion:** 2017-04-03
- **Final completion:** 2017-04-03
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Difficulty in recruitment
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416102, "Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02416102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*